Product Information
CMPDA is a monoclonal antibody that binds to activated dasatinib, which is an epidermal growth factor receptor tyrosine kinase inhibitor. CMPDA blocks the binding of dasatinib and other therapeutic agents to their receptor targets, thereby inhibiting cancer cell growth. In addition, it has been shown to reduce inflammation in mouse models of inflammatory bowel disease. CMPDA also inhibits angiogenesis by binding to the erythropoietin receptor and blocking the production of vascular endothelial growth factor (VEGF). This agent has been shown to have a strong inhibitory effect on fungal biomass.
Chemical properties
Technical inquiry about: 3D-FQA60777 CMPDA
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
